Vertex Pharma's £1.65 million ($2.05 million) gene-editing therapy for sickle cell disease (SCD), Casgevy, has been given the green light for use by the NHS in England under a managed access ...

Lilly is one of a clutch of companies looking to develop gene therapies for deafness caused by OTOF mutations, alongside the likes of Regeneron – which added a candidate called DB-OTO from its ...

Genes and Genetics News. Read today's medical research in genetics including what can damage genes, what can protect them, and more.

Nine News federal politics reporter Claudia Vrdoljak has sat down for an extended interview with Australia’s first female Muslim national cabinet member, Anne Aly. Added May 26th, 2025 Share ...

“The King owned the carpet – Shah Rukh Khan’s grand Met Gala 2025 debut was nothing short of iconic! Draped in regal black, crowned with confidence, and shining with charisma – he ...